Matthew K Harbaugh
CIK 1578368 · Chief Financial Officer · last filed 2025-12-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
41
Lifetime Open-Market Net
-$2.65M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Q | Chief Financial Officer | — | $150.65 | — | $0 | 1 | 2025-12-05 |
| NUVASIVE INC (NUVA) Delisted | EVP and CFO | 0 | $39.75 | $0 | $0 | 7 | 2023-09-05 |
| Keenova Therapeutics plc (MNK) Delisted | EVP & President, Spec Gen | 104,115 | $0.34 | $35.4K | -$2.65M | 32 | 2019-04-03 |
Recent Filings · Page 4 of 5
41 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-01-06 | Keenova Therapeutics plc (MNK) Delisted | Mixed | +3,517 | -$30.1K | EDGAR |
| 2014-12-04 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −297 | -$27.1K | EDGAR |
| 2014-12-03 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −2,085 | -$183.9K | EDGAR |
| 2014-02-04 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −127 | -$7.3K | EDGAR |
| 2014-01-06 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +3,206 | $0 | EDGAR |
| 2013-12-18 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −297 | -$15.3K | EDGAR |
| 2013-12-18 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −2,195 | -$114.1K | EDGAR |
| 2013-12-05 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −352 | -$18.1K | EDGAR |
| 2013-12-03 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −2,602 | -$135.2K | EDGAR |
| 2013-11-25 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +7,281 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.